drk-bsd nstob & west 19th sogat meeting, 14/15 june 2006, bern experience with roche´s cobas...
DESCRIPTION
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern BSD NSTOBBSD West Donations/year (2005) Samples/Day 1.15 mio ~ mio ~ Viral parameters HCV, HIV-1, HBV, HAV, PVB19 Routine testing with CAP/CTM96 since 1st Nov st July 2005 CAP/CTM96 Systems 6 x9 xTRANSCRIPT
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
Experience with Roche´s COBAS AmpliPrep/COBAS TaqMan96 automated PCR
system in two large blood bank settings
Lutz Pichl , DRK-Blutspendedienst WestChristine Jork, DRK-Blutspendedienst NSTOBChristine Jork, DRK-Blutspendedienst NSTOB
Lutz Pichl , DRK-Blutspendedienst West
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
DRK-BSD West
DRK-BSD NSTOB
Springe
Hagen
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
BSD NSTOB BSD WestDonations/year (2005)
Samples/Day1.15 mio~ 4.000
1.26 mio~ 4.000
Viral parameters HCV, HIV-1, HBV, HAV, PVB19
Routine testing with CAP/CTM96 since 1st Nov. 2005 1st July 2005
CAP/CTM96 Systems 6 x 9 x
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
BSD NSTOB BSD WestCAP/CTM96 combined via docking station for HBV, HCV and HIV-1
CAP/CTM96 combined via docking station for HBV, HCV and HIV-1+ ventilation shaft for waste air
2 CAP/CTM96 for HCV
2 CAP/CTM96 for HIV-1
1 CAP/CTM96 for HBV
1 CAP for TNAI HAV/PVB19 RealArt LC PCR Reagents (QIAGEN Diagnostics), LightCycler 1.2 (Roche)
3 CAP/CTM96 for HCV
3 CAP/CTM96 for HIV-1
3 CAP/CTM96 for HBV
2 CAP for TNAI HAV/PVB19 RealArt LC PCR Reagents (QIAGEN Diagnostics), LightCycler 2.0 (Roche)
System configuration
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
BSD NSTOB BSD West
Samples tested 668,469 (11/2005 – 05/2006)
Pool size 96 96
Invalidity rate (HCV / HIV-1 / HBV)
Failure rate0.9 %
(hardware error)< 0.2 %
(clot, hardware error)
NAT only positives
842,751(07/2005 -05/2006)
HCV: 2 (05) 2 (06)HBV: 1
HCV: Ø 0.27 %HIV-1: Ø 0.12 %HBV: Ø 0.05 %
HIV-1: 2 (06)HBV: 1 (06)
HCV: Ø 1.68 %HIV-1: Ø 0.15 %HBV: Ø 0.14 %
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
95% detection limits BSD NSTOB BSD West
HBV 675 IUWHO/ml SD 251 IUWHO/ml SD
HCV 582 IUWHO/ml SD 624 IUWHO/ml SD
HIV-1 4315 IUWHO/ml SD 7876 IUWHO/ml SD
PVB19 5784 IUWHO/ml SD 5735 IUWHO/ml SD
HAV 21420 IUWHO/ml SD 6157 IUWHO/ml SD
SD = single donation in pool of 96 samples
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
Turn around time
CAP/CTM M
ainten
ance
Sample
Prep
aratio
n
1 h
NA Extr
actio
n
2 h
Amplific
ation
&
Detecti
on
HIV-1 3h 15‘
HCV 2h 40‘
HBV 2h 10‘
HAV/PVB 50‘
Poolin
g
0,5 h
Result
Vali
datio
n
Data Tran
sfer (
LIMS)
15-30‘
6 a.m. ~1 p.m.
DRK-BSD NSTOB & West 19th SoGAT Meeting, 14/15 June 2006, Bern
Pro Con
fully automatedintensive maintenance caused by
high system complexity
short hands-on timeadditional manual result
interpretation
IVD conform only for single samplesoff label use for minipool testing;
extensive validation studies
virus enrichment steps unnecessary high sample volume (1050 µl brutto volume)
automation of front end sample handling is users responsibility
in-house solutions
Pros & Cons of CAP/CTM96 System